USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of approximately one year. Its Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair by providing topical nourishment, moisturization and protection.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Personal Products - NEC
- Sub-Industry: Personal Products
- Symbol: NYSE:USNA
- CUSIP: 90328M10
- Web: www.usana.com
Capitalization:- Market Cap: $1.43 billion
- Outstanding Shares: 24,445,000
Average Prices:- 50 Day Moving Avg: $59.98
- 200 Day Moving Avg: $60.27
- 52 Week Range: $52.55 - $75.00
P/E:- Trailing P/E Ratio: 14.91
- Foreward P/E Ratio: 13.47
- P/E Growth: 1.48
Sales & Book Value:- Annual Revenue: $1.02 billion
- Price / Sales: 1.40
- Book Value: $15.56 per share
- Price / Book: 3.77
Profitability:- EBIDTA: $147.32 million
- Net Margins: 9.47%
- Return on Equity: 28.93%
- Return on Assets: 20.74%
Debt:- Current Ratio: 2.44%
- Quick Ratio: 1.93%
Misc:- Average Volume: 117,781 shs.
- Beta: 1.1
- Short Ratio: 8.18
Frequently Asked Questions for USANA Health Sciences (NYSE:USNA)
What is USANA Health Sciences' stock symbol?
USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."
How will USANA Health Sciences' stock buyback program work?
USANA Health Sciences declared that its board has authorized a stock buyback program on Wednesday, July 26th 2017, which allows the company to repurchase $64,600,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 46% of its stock through open market purchases. Stock repurchase programs are often a sign that the company's board of directors believes its stock is undervalued.
How were USANA Health Sciences' earnings last quarter?
USANA Health Sciences, Inc. (NYSE:USNA) released its quarterly earnings data on Tuesday, July, 25th. The company reported $0.98 earnings per share for the quarter, missing the Zacks' consensus estimate of $1.06 by $0.08. The company earned $257.10 million during the quarter, compared to analysts' expectations of $273.61 million. USANA Health Sciences had a return on equity of 28.93% and a net margin of 9.47%. The company's revenue was down .5% compared to the same quarter last year. During the same period in the previous year, the company earned $2.07 EPS. View USANA Health Sciences' Earnings History.
When will USANA Health Sciences make its next earnings announcement?
What guidance has USANA Health Sciences issued on next quarter's earnings?
USANA Health Sciences issued an update on its FY17 earnings guidance on Tuesday, July, 25th. The company provided earnings per share guidance of $3.50-3.70 for the period, compared to the Thomson Reuters consensus estimate of $4.06. The company issued revenue guidance of $1.02-1.03 billion, compared to the consensus revenue estimate of $1.07 billion.
Where is USANA Health Sciences' stock going? Where will USANA Health Sciences' stock price be in 2017?
1 equities research analysts have issued 12-month price objectives for USANA Health Sciences' shares. Their forecasts range from $70.00 to $70.00. On average, they expect USANA Health Sciences' share price to reach $70.00 in the next twelve months. View Analyst Ratings for USANA Health Sciences.
Who are some of USANA Health Sciences' key competitors?
Some companies that are related to USANA Health Sciences include Agios Pharmaceuticals (AGIO), BeiGene (BGNE), Intercept Pharmaceuticals (ICPT), Ligand Pharmaceuticals Incorporated (LGND), Evotec AG (EVTCY), HealthEquity (HQY), Nevro Corp. (NVRO), The Medicines Company (MDCO), GW Pharmaceuticals PLC (GWPH), Neogen Corporation (NEOG), China Biologic Products (CBPO), Ultragenyx Pharmaceutical (RARE), Spark Therapeutics (ONCE), Sarepta Therapeutics (SRPT), Allscripts Healthcare Solutions (MDRX), Supernus Pharmaceuticals (SUPN), LifePoint Health (LPNT) and Loxo Oncology (LOXO).
Who are USANA Health Sciences' key executives?
USANA Health Sciences' management team includes the folowing people:
- Myron W. Wentz Ph.D., Chairman, Independent Director
- Jim Brown, President, Chief Operating Officer
- Kevin G. Guest, Chief Executive Officer, Independent Director
- G. Douglas Hekking, Chief Financial Officer
- Josh Foukas, Executive Vice President - Legal
- Brent Neidig, Executive Vice President - China
- Walter Noot, Chief Information Officer
- Douglas Braun, Chief Marketing Officer
- Robert A. Sinnott Ph.D, Chief Scientific Officer
- James H. Bramble, Chief Legal Officer and Corporate Secretary
Who owns USANA Health Sciences stock?
USANA Health Sciences' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (7.79%), FMR LLC (6.39%), Vanguard Group Inc. (3.92%), Dimensional Fund Advisors LP (2.84%), Schroder Investment Management Group (2.29%) and Nordea Investment Management AB (1.34%). Company insiders that own USANA Health Sciences stock include Dave Wentz, Deborah Woo, Doug Braun, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jerry G Mcclain, Jim Brown, Kevin Guest, Myron W Wentz, Paul A Jones, Rick Stambaugh and Robert Auciaux. View Institutional Ownership Trends for USANA Health Sciences.
Who sold USANA Health Sciences stock? Who is selling USANA Health Sciences stock?
USANA Health Sciences' stock was sold by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc., Citadel Advisors LLC, Menta Capital LLC, Prudential Financial Inc., Spark Investment Management LLC, Tudor Investment Corp ET AL, Acadian Asset Management LLC and Citigroup Inc.. Company insiders that have sold USANA Health Sciences stock in the last year include Deborah Woo, Gilbert A Fuller, Global Ltd Gull, James Bramble, Myron W Wentz, Paul A Jones and Robert Auciaux. View Insider Buying and Selling for USANA Health Sciences.
Who bought USANA Health Sciences stock? Who is buying USANA Health Sciences stock?
USANA Health Sciences' stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Arrowstreet Capital Limited Partnership, FMR LLC, Old Mutual Global Investors UK Ltd., Schroder Investment Management Group, TIAA CREF Investment Management LLC, Vanguard Group Inc. and GSA Capital Partners LLP. View Insider Buying and Selling for USANA Health Sciences.
How do I buy USANA Health Sciences stock?
Shares of USANA Health Sciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is USANA Health Sciences' stock price today?
One share of USANA Health Sciences stock can currently be purchased for approximately $58.60.
MarketBeat Community Rating for USANA Health Sciences (NYSE USNA)MarketBeat's community ratings are surveys of what our community members think about USANA Health Sciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for USANA Health Sciences (NYSE:USNA)Earnings History by Quarter for USANA Health Sciences (NYSE USNA)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/23/2017 | | | | | | | N/A |  |
| 7/25/2017 | Q2 2017 | $1.06 | $0.98 | $273.61 million | $257.10 million | View | N/A | |
| 5/2/2017 | Q1 2017 | $0.92 | $0.91 | | $255.32 million | View | Listen | |
| 2/7/2017 | Q416 | $0.94 | $0.87 | $253.52 million | $252.90 million | View | Listen | |
| 10/25/2016 | Q316 | $2.13 | $2.40 | $263.37 million | $254.22 million | View | Listen | |
| 7/26/2016 | Q2 | $2.05 | $2.07 | $256.66 million | $258.50 million | View | Listen | |
| 5/3/2016 | Q116 | $1.81 | $1.77 | $244.05 million | $240.45 million | View | Listen | |
| 2/9/2016 | Q415 | $2.00 | $1.83 | $250.82 million | $232.60 million | View | Listen | |
| 11/3/2015 | Q315 | $1.76 | $1.92 | $230.79 million | $233.30 million | View | Listen | |
| 8/4/2015 | Q215 | $1.60 | $1.92 | $211.86 million | $233.20 million | View | Listen | |
| 5/5/2015 | Q1 | $1.30 | $1.50 | $198.21 million | $219.40 million | View | Listen | |
| 2/10/2015 | Q414 | $1.93 | $1.65 | $219.10 million | $227.90 million | View | Listen | |
| 10/28/2014 | Q314 | $1.37 | $1.47 | $190.50 million | $191.90 million | View | Listen | |
| 7/29/2014 | Q214 | $1.50 | $1.36 | $198.30 million | $188.30 million | View | Listen | |
| 4/29/2014 | Q114 | $1.30 | $1.15 | $185.85 million | $182.40 million | View | Listen | |
| 2/5/2014 | Q413 | $1.22 | $1.41 | $175.53 million | $186.30 million | View | Listen | |
| 10/23/2013 | Q313 | $1.14 | $1.16 | $172.40 million | $173.70 million | View | Listen | |
| 7/23/2013 | Q2 2013 | $1.33 | $1.72 | $176.60 million | $189.10 million | View | Listen | |
| 4/23/2013 | Q1 2013 | $1.16 | $1.28 | $171.77 million | $169.10 million | View | Listen | |
| 2/5/2013 | Q4 2012 | $1.21 | $1.27 | $165.80 million | $168.50 million | View | Listen | |
| 10/23/2012 | | $1.06 | $1.18 | | | View | N/A | |
| 7/24/2012 | | $0.92 | $1.11 | | | View | N/A | |
| 2/7/2012 | | $0.86 | $0.87 | | | View | N/A | |
| 10/25/2011 | | $0.76 | $0.81 | | | View | N/A | |
| 4/26/2011 | | $0.66 | $0.70 | | | View | N/A | |
| 2/8/2011 | | $0.84 | $0.75 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for USANA Health Sciences (NYSE:USNA)Current Year EPS Consensus Estimate: $3.79 EPS
Next Year EPS Consensus Estimate: $4.35 EPS
Dividend History for USANA Health Sciences (NYSE:USNA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for USANA Health Sciences (NYSE:USNA)Insider Ownership Percentage: 53.20%
Institutional Ownership Percentage: 43.57%
Insider Trades by Quarter for USANA Health Sciences (NYSE:USNA)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/21/2017 | James Bramble | Insider | Sell | 18,298 | $57.01 | $1,043,168.98 | |
| 8/2/2017 | Global Ltd Gull | Major Shareholder | Sell | 14,533 | $56.71 | $824,166.43 | |
| 8/2/2017 | Myron W Wentz | Director | Sell | 40,000 | $56.59 | $2,263,600.00 | |
| 8/1/2017 | Global Ltd Gull | Major Shareholder | Sell | 25,467 | $56.52 | $1,439,394.84 | |
| 7/31/2017 | Gilbert A Fuller | Director | Sell | 1,483 | $57.67 | $85,524.61 | |
| 7/5/2017 | Myron W Wentz | Director | Sell | 40,000 | $64.15 | $2,566,000.00 | |
| 6/2/2017 | Myron W Wentz | Director | Sell | 40,000 | $64.99 | $2,599,600.00 | |
| 6/1/2017 | Paul A Jones | Insider | Sell | 9,851 | $64.50 | $635,389.50 | |
| 5/11/2017 | Gilbert A Fuller | Director | Sell | 4,884 | $64.38 | $314,431.92 | |
| 5/1/2017 | Myron W Wentz | Director | Sell | 40,000 | $56.39 | $2,255,600.00 | |
| 4/5/2017 | Global Ltd Gull | Major Shareholder | Sell | 16,436 | $56.54 | $929,291.44 | |
| 4/5/2017 | Myron W Wentz | Director | Sell | 40,000 | $56.81 | $2,272,400.00 | |
| 4/4/2017 | Global Ltd Gull | Major Shareholder | Sell | 10,040 | $56.69 | $569,167.60 | |
| 4/3/2017 | Global Ltd Gull | Major Shareholder | Sell | 13,524 | $57.22 | $773,843.28 | |
| 3/8/2017 | Global Ltd Gull | Major Shareholder | Sell | 20,000 | $57.15 | $1,143,000.00 | |
| 2/8/2017 | Global Ltd Gull | Major Shareholder | Sell | 20,000 | $55.87 | $1,117,400.00 | |
| 1/11/2017 | Myron W Wentz | Director | Sell | 20,000 | $61.04 | $1,220,800.00 | |
| 12/14/2016 | Myron W Wentz | Director | Sell | 20,000 | $61.41 | $1,228,200.00 | |
| 11/9/2016 | Myron W Wentz | Director | Sell | 10,000 | $123.99 | $1,239,900.00 | |
| 10/12/2016 | Global Ltd Gull | Major Shareholder | Sell | 10,000 | $146.35 | $1,463,500.00 | |
| 9/14/2016 | Global Ltd Gull | Major Shareholder | Sell | 10,000 | $134.67 | $1,346,700.00 | |
| 9/8/2016 | Deborah Woo | Insider | Sell | 1,058 | $140.00 | $148,120.00 | |
| 8/30/2016 | Paul A Jones | CFO | Sell | 5,067 | $138.50 | $701,779.50 | |
| 8/23/2016 | Deborah Woo | Insider | Sell | 2,621 | $138.94 | $364,161.74 | |
| 8/23/2016 | Robert Auciaux | Director | Sell | 2,317 | $138.79 | $321,576.43 | |
| 8/19/2016 | Deborah Woo | Insider | Sell | 4,590 | $133.12 | $611,020.80 | |
| 8/18/2016 | Deborah Woo | Insider | Sell | 5,041 | $131.15 | $661,127.15 | |
| 8/16/2016 | James Bramble | Insider | Sell | 9,339 | $131.33 | $1,226,490.87 | |
| 8/16/2016 | Jim Brown | COO | Sell | 9,104 | $131.36 | $1,195,901.44 | |
| 8/15/2016 | Kevin Guest | Insider | Sell | 16,285 | $131.08 | $2,134,637.80 | |
| 8/10/2016 | Global Ltd Gull | Major Shareholder | Sell | 10,000 | $135.08 | $1,350,800.00 | |
| 8/1/2016 | Gilbert A. Fuller | Director | Sell | 859 | $137.07 | $117,743.13 | |
| 7/13/2016 | Global Ltd Gull | Major Shareholder | Sell | 10,000 | $118.96 | $1,189,600.00 | |
| 6/8/2016 | Global Ltd Gull | Major Shareholder | Sell | 10,000 | $123.47 | $1,234,700.00 | |
| 6/7/2016 | Dave Wentz | Insider | Sell | 10,000 | $125.09 | $1,250,900.00 | |
| 5/11/2016 | Global Ltd Gull | Major Shareholder | Sell | 10,000 | $122.67 | $1,226,700.00 | |
| 4/13/2016 | Global Ltd Gull | Major Shareholder | Sell | 10,000 | $121.82 | $1,218,200.00 | |
| 3/9/2016 | Myron W Wentz | Director | Sell | 10,000 | $116.07 | $1,160,700.00 | |
| 3/4/2016 | Jerry G Mcclain | Director | Sell | 767 | $118.17 | $90,636.39 | |
| 2/24/2016 | Gilbert A Fuller | Director | Sell | 728 | $113.22 | $82,424.16 | |
| 2/10/2016 | Global Ltd Gull | Major Shareholder | Sell | 10,000 | $96.37 | $963,700.00 | |
| 1/13/2016 | Global Ltd Gull | Major Shareholder | Sell | 10,000 | $121.04 | $1,210,400.00 | |
| 12/17/2015 | Rick Stambaugh | insider | Sell | 7,059 | $130.18 | $918,940.62 | |
| 12/16/2015 | Doug Braun | CMO | Sell | 10,907 | $130.80 | $1,426,635.60 | |
| 12/15/2015 | Dave Wentz | Insider | Sell | 6,000 | $130.59 | $783,540.00 | |
| 12/15/2015 | Doug Braun | CMO | Sell | 2,748 | $132.00 | $362,736.00 | |
| 12/9/2015 | Myron W Wentz | Director | Sell | 10,000 | $133.18 | $1,331,800.00 | |
| 11/11/2015 | Global Ltd Gull | Major Shareholder | Sell | 10,000 | $133.71 | $1,337,100.00 | |
| 10/1/2015 | Myron W Wentz | Director | Sell | 10,000 | $131.85 | $1,318,500.00 | |
| 9/10/2015 | Myron W Wentz | Director | Sell | 7,000 | $138.32 | $968,240.00 | |
| 8/27/2015 | Deborah Woo | insider | Sell | 1,527 | $150.00 | $229,050.00 | |
| 8/17/2015 | Paul A Jones | CFO | Sell | 7,719 | $162.21 | $1,252,098.99 | |
| 8/12/2015 | Myron W Wentz | Director | Sell | 7,000 | $159.84 | $1,118,880.00 | |
| 7/8/2015 | Myron W Wentz | Director | Sell | 7,000 | $138.28 | $967,960.00 | |
| 6/10/2015 | Myron W Wentz | Director | Sell | 7,000 | $133.75 | $936,250.00 | |
| 6/9/2015 | Deborah Woo | Insider | Sell | 3,656 | $132.06 | $482,811.36 | |
| 5/14/2015 | Deborah Woo | Insider | Sell | 3,569 | $124.00 | $442,556.00 | |
| 5/12/2015 | Kevin Guest | Insider | Sell | 2,858 | $120.00 | $342,960.00 | |
| 5/11/2015 | Daniel A Macuga | Insider | Sell | 4,231 | $125.64 | $531,582.84 | |
| 5/11/2015 | Jim Brown | COO | Sell | 7,860 | $124.46 | $978,255.60 | |
| 4/8/2015 | Global Ltd Gull | Major Shareholder | Sell | 7,000 | $113.54 | $794,780.00 | |
| 2/12/2015 | Robert Auciaux | Director | Sell | 5,028 | $100.18 | $503,705.04 | |
| 1/14/2015 | Myron W Wentz | Director | Sell | 7,000 | $101.32 | $709,240.00 | |
| 12/16/2014 | Doug Braun | CMO | Sell | 9,969 | $101.01 | $1,006,968.69 | |
| 12/10/2014 | Myron W Wentz | Director | Sell | 102,755 | $100.25 | $10,301,188.75 | |
| 12/8/2014 | Myron W Wentz | Director | Sell | 184,245 | $104.65 | $19,281,239.25 | |
| 11/3/2014 | Dave Wentz | Insider | Sell | 19,780 | $114.68 | $2,268,370.40 | |
| 10/31/2014 | Ronald S Poelman | Director | Sell | 4,491 | $112.53 | $505,372.23 | |
| 10/30/2014 | Paul A Jones | CFO | Sell | 10,823 | $105.10 | $1,137,497.30 | |
| 10/8/2014 | Myron W Wentz | Director | Sell | 7,000 | $76.52 | $535,640.00 | |
| 9/10/2014 | Myron W Wentz | Director | Sell | 7,000 | $71.53 | $500,710.00 | |
| 8/25/2014 | Dave Wentz | Insider | Sell | 5,141 | $73.30 | $376,835.30 | |
| 7/9/2014 | Myron W Wentz | Director | Sell | 7,000 | $78.95 | $552,650.00 | |
| 6/13/2014 | Dave Wentz | Insider | Sell | 5,301 | $75.51 | $400,278.51 | |
| 6/11/2014 | Myron W Wentz | Director | Sell | 7,000 | $74.69 | $522,830.00 | |
| 6/10/2014 | Daniel A Macuga | Insider | Sell | 6,654 | $75.01 | $499,116.54 | |
| 5/30/2014 | Deborah Woo | Insider | Sell | 1,028 | $73.00 | $75,044.00 | |
| 5/28/2014 | Dave Wentz | Insider | Sell | 5,141 | $73.03 | $375,447.23 | |
| 5/28/2014 | Jerry G Mcclain | Director | Sell | 1,217 | $72.12 | $87,770.04 | |
| 5/22/2014 | Kevin Guest | Insider | Sell | 10,160 | $71.15 | $722,884.00 | |
| 5/21/2014 | Kevin Guest | Insider | Sell | 2,475 | $71.00 | $175,725.00 | |
| 5/19/2014 | James Bramble | Insider | Sell | 5,919 | $70.02 | $414,448.38 | |
| 5/14/2014 | Myron Wentz | Director | Sell | 14,000 | $73.78 | $1,032,920.00 | |
| 5/12/2014 | Deborah Woo | Insider | Sell | 11,336 | $70.03 | $793,860.08 | |
| 5/5/2014 | Deborah Woo | Insider | Sell | 3,512 | $71.00 | $249,352.00 | |
| 3/4/2014 | Myron Wentz | Director | Sell | 63,805 | $72.69 | $4,637,985.45 | |
| 2/11/2014 | Doug Braun | CMO | Sell | 8,139 | $70.46 | $573,473.94 | |
| 11/13/2013 | Myron Wentz | Director | Sell | 7,000 | $67.68 | $473,760.00 | |
| 10/9/2013 | Holdings Ltd Gull | major shareholder | Sell | 7,000 | $80.08 | $560,560.00 | |
| 9/11/2013 | Deborah Woo | Insider | Sell | 1,340 | $79.01 | $105,873.40 | |
| 9/11/2013 | Holdings Ltd Gull | major shareholder | Sell | 7,000 | $78.19 | $547,330.00 | |
| 9/5/2013 | Dave Wentz | Insider | Sell | 13,704 | $77.93 | $1,067,952.72 | |
| 9/3/2013 | Dave Wentz | Insider | Sell | 32,174 | $78.10 | $2,512,789.40 | |
| 8/14/2013 | Holdings Ltd Gull | major shareholder | Sell | 7,000 | $80.34 | $562,380.00 | |
| 8/1/2013 | Deborah Woo | Insider | Sell | 1,386 | $85.00 | $117,810.00 | |
| 7/26/2013 | Paul A Jones | CFO | Sell | 5,047 | $78.01 | $393,716.47 | |
| 7/25/2013 | Kevin Guest | Insider | Sell | 19,290 | $73.20 | $1,412,028.00 | |
| 7/25/2013 | Ronald S Poelman | Director | Sell | 6,380 | $73.20 | $467,016.00 | |
| 7/10/2013 | Holdings Ltd Gull | Major Shareholder | Sell | 7,000 | $78.22 | $547,540.00 | |
| 6/12/2013 | Holdings Ltd Gull | Major Shareholder | Sell | 7,000 | $70.96 | $496,720.00 | |
| 5/9/2013 | Robert Auciaux | Director | Sell | 2,664 | $55.92 | $148,970.88 | |
| 5/8/2013 | Holdings Ltd Gull | Major Shareholder | Sell | 7,000 | $56.59 | $396,130.00 | |
| 4/10/2013 | Holdings Ltd Gull | Major Shareholder | Sell | 7,000 | $47.45 | $332,150.00 | |
| 8/8/2012 | Myron W Wentz | Director | Sell | 7,000 | $44.21 | $309,470.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for USANA Health Sciences (NYSE:USNA)
Latest Headlines for USANA Health Sciences (NYSE:USNA)
| Source: |
|
| Date | Headline |
|---|
 | James Bramble Sells 18,298 Shares of USANA Health Sciences, Inc. (USNA) Stock
www.americanbankingnews.com - August 22 at 1:14 PM |
| USANA Health Sciences, Inc. (USNA) Upgraded by BidaskClub to "Sell"
www.americanbankingnews.com - August 22 at 12:44 PM |
 | USANA To Expand In Four European Countries Beginning Mid-year 2018 = Quick Facts - Nasdaq
www.nasdaq.com - August 19 at 8:43 AM |
 | USANA Breaks GUINNESS WORLD RECORDS™ Title at 25th Anniversary Event
finance.yahoo.com - August 18 at 8:24 AM |
| USANA Health Sciences, Inc. :USNA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017
finance.yahoo.com - August 18 at 8:24 AM |
| USANA Announces Plans To Expand In Four European Countries
finance.yahoo.com - August 18 at 8:24 AM |
| Matthews International Corporation (MATW) versus USANA Health Sciences (USNA) Head-To-Head Comparison
www.americanbankingnews.com - August 11 at 2:44 PM |
| See what the IHS Markit Score report has to say about USANA Health Sciences Inc.
finance.yahoo.com - August 10 at 3:27 PM |
| Global Ltd Gull Sells 25,467 Shares of USANA Health Sciences, Inc. (NYSE:USNA) Stock
www.americanbankingnews.com - August 2 at 7:46 PM |
| USANA Health Sciences, Inc. (USNA) Major Shareholder Sells $824,166.43 in Stock
www.americanbankingnews.com - August 2 at 7:46 PM |
| Insider Selling: USANA Health Sciences, Inc. (NYSE:USNA) Director Sells 40,000 Shares of Stock
www.americanbankingnews.com - August 2 at 7:26 PM |
 | The Real USANA Revealed - Seeking Alpha
seekingalpha.com - August 2 at 8:21 AM |
| USANA Joins Forces with Philippines Sports Commission-Philippines Sports Institute
finance.yahoo.com - August 2 at 8:21 AM |
| BidaskClub Downgrades USANA Health Sciences, Inc. (USNA) to Strong Sell
www.americanbankingnews.com - July 31 at 11:14 PM |
| Gilbert A. Fuller Sells 1,483 Shares of USANA Health Sciences, Inc. (USNA) Stock
www.americanbankingnews.com - July 31 at 7:44 PM |
| Reviewing USANA Health Sciences (USNA) and Herbalife LTD. (HLF)
www.americanbankingnews.com - July 29 at 4:24 PM |
| USANA Health Sciences (USNA) & Avon Products (AVP) Head to Head Comparison
www.americanbankingnews.com - July 28 at 4:13 PM |
| Edited Transcript of USNA earnings conference call or presentation 26-Jul-17 3:00pm GMT
finance.yahoo.com - July 27 at 8:59 AM |
| USANA Health Sciences, Inc. (USNA) Given New $70.00 Price Target at Pivotal Research
www.americanbankingnews.com - July 26 at 7:27 PM |
| USANA Health Sciences (USNA) Board of Directors Approves Stock Repurchase Program
www.americanbankingnews.com - July 26 at 12:01 PM |
 | Pre-Open Stock Movers 07/26: (TTPH) (IRBT) (AMD) Higher; (AMED) (USNA) (DVAX) Lower (more...) - StreetInsider.com
www.streetinsider.com - July 26 at 9:35 AM |
 | USANA Health Sciences shares drop after company misses earnings, cuts outlook - MarketWatch
www.marketwatch.com - July 26 at 9:35 AM |
| USANA Health Sciences Reports Second Quarter Financial Results
finance.yahoo.com - July 26 at 9:35 AM |
| USANA Health Sciences shares drop after company misses earnings, cuts outlook
finance.yahoo.com - July 26 at 9:35 AM |
| USANA Health posts 2Q profit
finance.yahoo.com - July 26 at 9:35 AM |
| USANA Health Sciences, Inc. breached its 50 day moving average in a Bullish Manner : USNA-US : July 26, 2017
finance.yahoo.com - July 26 at 9:35 AM |
| USANA Health Sciences, Inc. (NYSE:USNA) Issues Quarterly Earnings Results
www.americanbankingnews.com - July 25 at 10:13 PM |
| USANA Health Sciences, Inc. (NYSE:USNA) Issues FY17 Earnings Guidance
www.americanbankingnews.com - July 25 at 10:12 PM |
| Reviewing Unilever NV (UN) & USANA Health Sciences (USNA)
www.americanbankingnews.com - July 22 at 4:10 PM |
| USANA Health Sciences, Inc. (USNA) to Release Earnings on Tuesday
www.americanbankingnews.com - July 18 at 8:50 AM |
| USANA Health Sciences, Inc. (NYSE:USNA) Cut to "Sell" at BidaskClub
www.americanbankingnews.com - July 16 at 8:56 PM |
| Contrasting USANA Health Sciences (NYSE:USNA) & Unilever PLC (UL)
www.americanbankingnews.com - July 11 at 2:10 PM |
| USANA Health Sciences, Inc. – Value Analysis (NYSE:USNA) : July 10, 2017
finance.yahoo.com - July 11 at 9:04 AM |
| USANA Health Sciences, Inc. breached its 50 day moving average in a Bearish Manner : USNA-US : July 7, 2017
finance.yahoo.com - July 8 at 3:51 PM |
| USANA Schedules Second Quarter Earnings Release and Conference Call
finance.yahoo.com - July 4 at 8:27 AM |
| Increase Your Energy Levels As You Support Your Liver Health
finance.yahoo.com - June 29 at 4:03 PM |
| Two USANA Executives Honored by Utah Business Magazine
finance.yahoo.com - June 22 at 8:03 PM |
| USANA Health Sciences, Inc. (USNA) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - June 20 at 4:10 PM |
| Get Manly This June for National Men's Health Month
finance.yahoo.com - June 15 at 3:15 PM |
| BidaskClub Upgrades USANA Health Sciences, Inc. (USNA) to Buy
www.americanbankingnews.com - June 13 at 7:16 PM |
| USANA CEO Elected To Direct Selling Association Board Of Directors
finance.yahoo.com - June 13 at 9:14 AM |
| New USANA Magnesium Supplement Receives Seal of Approval from Third Party Assessor
finance.yahoo.com - June 12 at 7:56 PM |
| Head to Head Review: USANA Health Sciences (USNA) & Perrigo Company plc (PRGO)
www.americanbankingnews.com - June 11 at 10:04 AM |
| USANA Health Sciences: Strong Moat, Highly Profitable And Growing Sales
seekingalpha.com - June 9 at 1:38 AM |
| USANA Makes Global Impact During Inaugural World Service Week
finance.yahoo.com - June 7 at 8:43 AM |
| USANA's Vitamin D Supplement Given Seal of Approval and Named Top Pick by Independent Tester
finance.yahoo.com - June 7 at 12:30 AM |
| Critical Analysis: Perrigo Company plc (PRGO) and USANA Health Sciences (USNA)
www.americanbankingnews.com - June 4 at 7:28 AM |
| USANA Health Sciences, Inc. (USNA) Director Sells $2,599,600.00 in Stock
www.americanbankingnews.com - June 2 at 7:43 PM |
| ETFs with exposure to USANA Health Sciences, Inc. : June 1, 2017
finance.yahoo.com - June 2 at 3:13 AM |
| Paul A. Jones Sells 9,851 Shares of USANA Health Sciences, Inc. (USNA) Stock
www.americanbankingnews.com - June 1 at 4:28 PM |
USANA Health Sciences (USNA) Chart for Wednesday, August, 23, 2017
